Literature DB >> 26638158

Carcinoma ex-pleomorphic adenoma of the salivary glands has a high risk of progression when the tumor invades more than 2.5 mm beyond the capsule of the residual pleomorphic adenoma.

Miguel Rito1,2, Isabel Fonseca3,4.   

Abstract

Carcinoma ex-pleomorphic adenoma (CPA) is subclassified based on the extent of penetration of the malignant component beyond the fibrous capsule of the pre-existing pleomorphic adenoma (PA). These subclasses are considered to be prognostically significant since the non-invasive/minimally invasive groups have an excellent outcome. Nevertheless, there is no consensus as to the cutoff value to distinguish between minimal and wide invasion, even though the 2005 WHO classification defines 1.5 mm as cutoff. The objective of this study is to evaluate a consecutive series of CPA, in order to establish what the effect is of the extent of extra-capsular invasion on prognosis. Fifty-eight cases of CPA were reviewed to obtain demographic and pathological information. Extent of invasion was measured. Eleven cases were non-invasive, 9 had ≤1.5 mm invasion, and for the remainder, the depth of invasion ranged between 2.5 and >10 mm. Distant metastases or death did not occur in the first two groups. In the group with ≥2.5 mm invasion, 15 patients had progressive disease and 9 of them died. The minimum extent of invasion associated with tumor progression and death was 2.5 mm. Two histologically non-invasive carcinomas had regional lymph node metastasis. CPA with ≤1.5 mm depth of invasion has good prognosis. Nevertheless, the lymph node metastases found in two cases of this group question the concept that intracapsular/minimally invasive CPA has a prognosis similar to that of PA. The minimum extent of invasion associated with death was 2.5 mm, which is at variance with findings in other recent series. Thirteen cases with depth of invasion exceeding 2.5 mm did well, confirming that additional factors should be considered in the clinical management of these patients.

Entities:  

Keywords:  Carcinoma ex pleomorphic adenoma; Cut-off values; Extent of invasion; Tumor progression

Mesh:

Year:  2015        PMID: 26638158     DOI: 10.1007/s00428-015-1887-4

Source DB:  PubMed          Journal:  Virchows Arch        ISSN: 0945-6317            Impact factor:   4.064


  25 in total

1.  Tumors of the major salivary glands.

Authors:  F W FOOTE; E L FRAZELL
Journal:  Cancer       Date:  1953-11       Impact factor: 6.860

2.  Carcinoma ex pleomorphic adenoma with special reference to the prognostic significance of histological progression: a clinicopathological investigation of 41 cases.

Authors:  Christoph Weiler; Pamela Zengel; Jacqueline E van der Wal; Orlando Guntinas-Lichius; Stephan Schwarz; John D Harrison; Thomas Kirchner; Stephan Ihrler
Journal:  Histopathology       Date:  2011-10       Impact factor: 5.087

Review 3.  Salivary duct carcinoma. Clinicopathologic and immunohistochemical review of 26 cases.

Authors:  J E Lewis; B C McKinney; L H Weiland; J A Ferreiro; K D Olsen
Journal:  Cancer       Date:  1996-01-15       Impact factor: 6.860

4.  Prognostic factors of recurrence in salivary carcinoma ex pleomorphic adenoma, with emphasis on the carcinoma histologic subtype: a clinicopathologic study of 43 cases.

Authors:  Nora Katabi; Daniel Gomez; David S Klimstra; Diane L Carlson; Nancy Lee; Ronald Ghossein
Journal:  Hum Pathol       Date:  2010-03-24       Impact factor: 3.466

Review 5.  Targeted therapy with trastuzumab for advanced salivary ductal carcinoma: case report and literature review.

Authors:  Orit Kaidar-Person; Salem Billan; Abraham Kuten
Journal:  Med Oncol       Date:  2011-03-06       Impact factor: 3.064

6.  Carcinoma ex pleomorphic adenoma (CXPA): immunoprofile of the cells involved in carcinomatous progression.

Authors:  A Altemani; M T Martins; L Freitas; F Soares; N S Araújo; V C Araújo
Journal:  Histopathology       Date:  2005-06       Impact factor: 5.087

7.  Non-invasive (intracapsular) carcinoma ex pleomorphic adenoma: recognition of focal carcinoma by HER-2/neu and MIB1 immunohistochemistry.

Authors:  S Di Palma; A Skálová; T Vanìèek; R H W Simpson; I Stárek; I Leivo
Journal:  Histopathology       Date:  2005-02       Impact factor: 5.087

Review 8.  An update on grading of salivary gland carcinomas.

Authors:  Raja R Seethala
Journal:  Head Neck Pathol       Date:  2009-02-25

Review 9.  Malignant mixed tumors arising in salivary glands. I. Carcinomas arising in benign mixed tumors: a clinicopathologic study.

Authors:  V A LiVolsi; K H Perzin
Journal:  Cancer       Date:  1977-05       Impact factor: 6.860

10.  Noninvasive and minimally invasive carcinoma ex mixed tumor: a clinicopathologic and ploidy study of 12 patients with major salivary tumors of low (or no?) malignant potential.

Authors:  M Brandwein; A G Huvos; I Dardick; M J Thomas; N D Theise
Journal:  Oral Surg Oral Med Oral Pathol Oral Radiol Endod       Date:  1996-06
View more
  6 in total

Review 1.  Salivary duct carcinoma: Updates in histology, cytology, molecular biology, and treatment.

Authors:  Masato Nakaguro; Yuichiro Tada; William C Faquin; Peter M Sadow; Lori J Wirth; Toshitaka Nagao
Journal:  Cancer Cytopathol       Date:  2020-05-18       Impact factor: 5.284

2.  Histological, immunohistological and molecular characteristics of intraductal precursor of carcinoma ex pleomorphic adenoma support a multistep carcinogenic process.

Authors:  Stephan Ihrler; Orlando Guntinas-Lichius; Abbas Agaimy; Agnes Wolf; Martin Mollenhauer
Journal:  Virchows Arch       Date:  2017-03-28       Impact factor: 4.064

3.  Diplopia: a unique presentation of recurrence of a salivary gland carcinoma.

Authors:  David Mackinlay; Aaron Stephen James Ferguson; Sharon White; Jaiganesh Manickavasagam
Journal:  BMJ Case Rep       Date:  2019-05-05

4.  Basal Cell Adenoma and Basal Cell Adenocarcinoma: a 50-year Experience From a Single Institution.

Authors:  Miguel Rito; Susana Esteves; Isabel Fonseca
Journal:  Head Neck Pathol       Date:  2022-08-10

5.  Nasopharyngeal Carcinoma Ex Pleomorphic Adenoma: Case Report and Comprehensive Literature Review.

Authors:  Ellen L Tokarz; Adian A Ong; Mark S Burke
Journal:  Case Rep Otolaryngol       Date:  2021-02-26

6.  Perfusion MR imaging detection of carcinoma arising from preexisting salivary gland pleomorphic adenoma by computer-assisted analysis of time-signal intensity maps.

Authors:  Ikuo Katayama; Sato Eida; Shuichi Fujita; Yuka Hotokezaka; Misa Sumi; Takashi Nakamura
Journal:  PLoS One       Date:  2017-05-22       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.